SOL is not trading, it’s an appreciation thesis.
Price: US$105.
After months between US$70–90, #SOL broke the consolidation with strong volume. US$93–98 turned into support; US$110–125 is the next resistance.
The fundamentals stand out: #Solana processed 9.8 billion transactions in Q2/26, has US$16.3B in stablecoins, and US$3.6B in RWA. SOL ETFs have already surpassed US$1B in assets.
Charles Schwab also announced plans to offer SOL to its clients, expanding institutional access.
Projection: US$125: +19% US$150: +43% US$180: +71% US$220: +109% US$250: +138%
$
My take: BUY for the medium/long term. Not because of the next run-up, but because of the combination of adoption, institutional liquidity, and infrastructure improvements.
The market may correct, but below US$100 the risk/reward ratio becomes especially attractive.
Not a price promise. It’s a thesis.
$SOL
Price: US$105.
After months between US$70–90, #SOL broke the consolidation with strong volume. US$93–98 turned into support; US$110–125 is the next resistance.
The fundamentals stand out: #Solana processed 9.8 billion transactions in Q2/26, has US$16.3B in stablecoins, and US$3.6B in RWA. SOL ETFs have already surpassed US$1B in assets.
Charles Schwab also announced plans to offer SOL to its clients, expanding institutional access.
Projection: US$125: +19% US$150: +43% US$180: +71% US$220: +109% US$250: +138%
$
My take: BUY for the medium/long term. Not because of the next run-up, but because of the combination of adoption, institutional liquidity, and infrastructure improvements.
The market may correct, but below US$100 the risk/reward ratio becomes especially attractive.
Not a price promise. It’s a thesis.
$SOL